• LAST PRICE
    37.0900
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    ---/ ---
  • Ask / Lots
    ---/ ---
  • Open / Previous Close
    0.0000 / 37.0900
  • Day Range
    ---
  • 52 Week Range
    Low 6.0000
    High 37.8000
  • Volume
    ---
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Monday's close: 36.92
TimeVolumeNVCN
10:29 ET20037
10:51 ET10036.93
12:17 ET20036.97
02:14 ET10037.1
03:30 ET30037.09
03:32 ET10037.09
03:42 ET50037.09
03:46 ET10037.09
03:53 ET100037.09
03:55 ET100037.09
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
CanadaNVCN
Neovasc Inc
102.1M
-2.3x
---
CanadaPINK
Perimeter Medical Imaging AI Inc
106.4M
-6.6x
---
CanadaMIR
MedMira Inc
87.6M
-43.6x
---
CanadaTLT
Theralase Technologies Inc
75.8M
-12.7x
---
CanadaBLO
Cannabix Technologies Inc
48.5M
-14.5x
---
CanadaVHI
Vitalhub Corp
116.5M
120.0x
---
As of 2023-01-31

Company Information

Neovasc Inc. is a Canada-based specialty medical device company. The Company develops, manufactures, and markets products for the cardiovascular marketplace. The Company is engaged in the development of minimally invasive therapies in cardiovascular care: refractory angina and mitral valve regurgitation. The Company's products include the Neovasc Reducer (Reducer), for the treatment of refractory angina, a painful and debilitating condition that occurs when the coronary vasculature delivers an inadequate supply of blood to the heart muscle; and the Tiara (Tiara), for the transcatheter treatment of mitral valve disease, which is under clinical investigation in the United States, Canada, Israel, and Europe. The Company operates through the development, manufacturing, and marketing of medical devices segment. Its wholly owned subsidiaries include Neovasc Medical Inc., Neovasc Tiara Inc., Neovasc (US) Inc., Neovasc Medical Ltd., B-Balloon Ltd., Neovasc GmbH, and Neovasc Management Inc.

Contact Information

Headquarters
Richmond, 5138-13562 Maycrest WayRICHMOND, BC, Canada V6V 2J7
Phone
604-270-4344
Fax
604-270-4344

Executives

Independent Chairman of the Board
Steven Rubin
President, Chief Executive Officer, Director
Fred Colen
Chief Financial Officer, Corporate Secretary
Christopher Clark
Chief Operating Officer
Bill Little
Vice President - Regulatory Affairs, Global Angina Therapies
Lisa Becker

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$102.7M
Revenue (TTM)
$4.2M
Shares Outstanding
2.8M
Neovasc Inc does not pay a dividend.
Beta
2.18
EPS
$-16.47
Book Value
$25.83
P/E Ratio
-2.3x
Price/Sales (TTM)
24.7
Price/Cash Flow (TTM)
---
Operating Margin
-857.91%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.